Pancreatic Cancer Research

ResearcherUniversity of WestminsterActive in the last 2 years

Maria Mortoglou

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4394-4549; OpenAlex author ID A5050225810. Sources: OpenAlex.

Their work

Papers
9 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2021: 3 papers · 2022: 3 papers · 2023: 2 papers · 2024: 1 paper

Papers 9

  1. miR-210 Mediated Hypoxic Responses in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1021/acsomega.4c08947↗
  2. Inhibiting CDK4/6 in pancreatic ductal adenocarcinoma via microRNA-21. Co-author DOI 10.1016/j.ejcb.2023.151318↗
  3. Impact of Hypoxia-Induced miR-210 on Pancreatic Cancer. First author DOI 10.3390/cimb45120611↗
  4. Role of microRNAs in response to cadmium chloride in pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00204-021-03196-9↗
  5. microRNA-21 Regulates Stemness in Pancreatic Ductal Adenocarcinoma Cells. Co-author DOI 10.3390/ijms23031275↗
  6. Nickel's Role in Pancreatic Ductal Adenocarcinoma: Potential Involvement of microRNAs. Co-author DOI 10.3390/toxics10030148↗
  7. Non-coding RNAs in pancreatic ductal adenocarcinoma: New approaches for better diagnosis and therapy. Co-author DOI 10.1016/j.tranon.2021.101090↗
  8. The Role of CDK4 in the Pathogenesis of Pancreatic Cancer. First author DOI 10.3390/healthcare9111478↗
  9. Peptidylarginine Deiminase Inhibitor Application, Using Cl-Amidine, PAD2, PAD3 and PAD4 Isozyme-Specific Inhibitors in Pancreatic Cancer Cells, Reveals Roles f… Co-author DOI 10.3390/ijms22031396↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Pinar Uysal Onganer · 9 shared papers, 2021–2024 · strength 1.85
  2. Mutian Lian · 2 shared papers, 2023–2024 · strength 0.59
  3. Elif Damla Arısan · 2 shared papers, 2021–2022 · strength 0.35
  4. Sigrun Lange · 2 shared papers, 2021–2022 · strength 0.35
  5. Aleksandra Buha Djordjević · 2 shared papers, 2022 · strength 0.32
  6. David Wallace · 2 shared papers, 2022 · strength 0.32
  7. Emily Jiggens · 1 shared paper, 2021 · strength 0.19
  8. Hemant Mahendrakumar Kocher · 1 shared paper, 2021 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.